P3 Health Partners (PIIIW) Cash & Equivalents (2019 - 2025)

P3 Health Partners (PIIIW) has 7 years of Cash & Equivalents data on file, last reported at $25.0 million in Q4 2025.

• For the quarter ending Q4 2025, Cash & Equivalents fell 35.57% year-over-year to $25.0 million; the trailing twelve-month figure through Dec 2025 stood at $25.0 million (down 35.57% YoY), and the FY2025 full-year result was $25.0 million, down 35.57% from the prior year.
• Cash & Equivalents for Q4 2025 stood at $25.0 million, down from $37.7 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $110.3 million in Q1 2022 and bottomed at $4.3 million in Q3 2021.
• The 5-year median for Cash & Equivalents is $37.0 million (2023), against an average of $38.7 million.
• The widest annual swing landed in 2022, when Cash & Equivalents surged 692.27%; it then sank 93.48% in 2023.
• A 5-year view of Cash & Equivalents shows it stood at $5.3 million in 2021, then soared by 230.13% to $17.5 million in 2022, then soared by 107.54% to $36.3 million in 2023, then advanced by 6.83% to $38.8 million in 2024, then sank by 35.57% to $25.0 million in 2025.
• The last three Cash & Equivalents figures came in at $25.0 million (Q4 2025), $37.7 million (Q3 2025), and $38.6 million (Q2 2025), per Business Quant data.

Peer Comparison